The 2nd ADC Payload Summit is your exclusive platform for exploring discovery, medicinal chemistry, and pre-clinical insights into the next generation of ADC Payloads.
From optimised Tubulin and DNA Damaging agents to the latest TOPO I inhibitors, to exploring exciting new payload modes of action like molecular glues, RNA Poly II inhibitors, and STING agonists – we’ve got you covered.
This is your opportunity to hear in-depth presentations from leading ADC developers focussed on physiochemical structural modifications and novel discoveries in the ADC payload field with the likes of Heidelberg Pharma, Merck ADC, Ryvu Therapeutics, Eisai, and many more.
